Literature DB >> 1382995

The influence of orientation and number of copies of T and B cell epitopes on the specificity and affinity of antibodies induced by chimeric peptides.

C Partidos1, C Stanley, M Steward.   

Abstract

CBA and TO mice were immunized with chimeric peptide immunogens consisting of B cell (residues 404-414) and T cell (residues 288-302) epitopes from the F protein of measles virus. The chimeras were co-linearly synthesized to contain one or two copies of the T cell epitope linked to one or two copies of the B cell epitope via a glycine.glycine spacer. Two orientations were synthesized such that the T cell epitope(s) were located at either the amino or carboxyl terminus of the B cell epitope(s). The levels of antibody induced following immunization with the chimeras were assessed by enzyme-linked immunosorbent assay using microtiter plates coated with either the homologous chimera or the B cell epitope sequence. The affinities of the anti-chimera antibodies for the B cell epitope were assessed by a fluid-phase double-isotope radioimmunoassay. All the chimeras induced good antibody responses in both strains of mice with specificity for the B cell epitope. Chimeras containing two copies of the T cell epitope induced antibodies with higher affinity for the B cell epitope than did chimeras containing one copy of the T cell epitope or two copies of the B cell epitope. Furthermore, the amino terminal location of the T cell epitope in relation to the B cell epitope in the chimera induced higher affinity anti-B cell antibody than did the reverse orientation. These results suggest that orientation of epitopes and amino acid composition of chimeric peptides affect antigen processing and presentation to T cells which govern both the specificity and affinity of antibody produced. Thus, for the production of synthetic peptide immunogens with vaccine potential, attention needs to be given to the number and orientation of the component epitopes required to produce highest affinity antibody.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1382995     DOI: 10.1002/eji.1830221030

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  13 in total

1.  Mapping antigenic sites of an immunodominant surface lipoprotein of Mycoplasma agalactiae, AvgC, with the use of synthetic peptides.

Authors:  Antonella Santona; Franco Carta; Peppinetta Fraghí; Franco Turrini
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

2.  Induction of measles virus-specific cytotoxic T-cell responses after intranasal immunization with synthetic peptides.

Authors:  C D Partidos; P Vohra; M W Steward
Journal:  Immunology       Date:  1996-02       Impact factor: 7.397

3.  An antigenic peptide inducing cross-reacting antibodies inhibiting the interaction of Streptococcus mutans PAc with human salivary components.

Authors:  H Senpuku; T Miyauchi; N Hanada; T Nisizawa
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

4.  Epitope mapping of the outer membrane protein P5-homologous fimbrin adhesin of nontypeable Haemophilus influenzae.

Authors:  L A Novotny; J A Jurcisek; M E Pichichero; L O Bakaletz
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

5.  Tandem truncated rotavirus VP8* subunit protein with T cell epitope as non-replicating parenteral vaccine is highly immunogenic.

Authors:  Xiaobo Wen; Dianjun Cao; Ronald W Jones; Yasutaka Hoshino; Lijuan Yuan
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

6.  Influence of epitope polarity and adjuvants on the immunogenicity and efficacy of a synthetic peptide vaccine against Semliki Forest virus.

Authors:  I M Fernández; A Snijders; B J Benaissa-Trouw; M Harmsen; H Snippe; C A Kraaijeveld
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

7.  The potential of immunization with synthetic peptides to overcome the immunosuppressive effect of maternal anti-measles virus antibodies in young mice.

Authors:  O E Obeid; M W Steward
Journal:  Immunology       Date:  1994-05       Impact factor: 7.397

8.  Identification and characterization of dominant helper T-cell epitopes in the nucleocapsid protein of severe acute respiratory syndrome coronavirus.

Authors:  Jincun Zhao; Qianrong Huang; Wei Wang; Yan Zhang; Ping Lv; Xiao-Ming Gao
Journal:  J Virol       Date:  2007-03-28       Impact factor: 5.103

9.  The affinity of IgG antibodies to gag p24 and p17 in HIV-1-infected patients correlates with disease progression.

Authors:  D Chargelegue; C M Stanley; C M O'Toole; B T Colvin; M W Steward
Journal:  Clin Exp Immunol       Date:  1995-02       Impact factor: 4.330

10.  Immune-tolerant elastin-like polypeptides (iTEPs) and their application as CTL vaccine carriers.

Authors:  S Cho; S Dong; K N Parent; M Chen
Journal:  J Drug Target       Date:  2015-08-25       Impact factor: 5.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.